BSF Enterprise’s Post

𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗱 𝗶𝗻 𝗧𝗵𝗶𝘀 𝗠𝗼𝗿𝗻𝗶𝗻𝗴’𝘀 𝗟𝗦𝗘 𝗨𝗽𝗱𝗮𝘁𝗲 We are pleased to announce the successful completion of a £500,000 fundraising, demonstrating strong investor confidence in our vision and capabilities. These funds will accelerate progress across our subsidiaries, driving advancements in lab-grown leather, cultivated meat, regenerative medicine through our corneal technology, and the launch of CytoBoost™—a next-generation cell culture additive addressing diverse markets. This strategic investment strengthens our ability to achieve key milestones and deliver innovative biotechnological solutions that meet growing market demand, while supporting a more sustainable future. Read the full announcement here: https://lnkd.in/g45Q2YUE #BSFA #BSFAF #LabGrownMeat #CultivatedMeat #LabGrownLeather #Biotech #SustainableBiotech #CornealTreatment #HealthCareInnovation #BSFEnterprise #3DBT #KeratoLtd #Biotechnology @BSF_Enterprise @3D_BioTissues

  • graphical user interface, text, chat or text message
Samir Sofi (MBA)

Senior Business Developer | Creating Strategic Partnerships for Industry-Leading Events | Driving Growth for High-Impact Industry Events

3mo

Keep growing

Like
Reply

To view or add a comment, sign in

Explore topics